bubbleCPAP CONTINUOUS POSITIVE AIRWAY PRESSURE

Global Health Challenge:

 

Acute respiratory infections are the leading cause of global child mortality and respiratory conditions associated with premature birth contribute to about 30% of neonatal death. In developed health systems, such conditions can be treated using bubble Continuous Positive Airway Pressure (bubbleCPAP), a therapy that delivers pressurized flow to an infant to prevent air sac collapse and makes breathing easier. However, the typical bubbleCPAP setup used in such settings costs anywhere from $6,000, making it inaccessible to most health facilities in developing countries. As such, the standard of care in resource-constrained settings for babies in respiratory distress is usually low-flow oxygen therapy, which on its own is inadequate.

 

Rice360 Solution:

 

In partnership with Queen Elizabeth Central Hospital, Baylor College of Medicine, and 3rd Stone Design, Rice360 has developed a low-cost, high-performance bubbleCPAP system to treat infants with respiratory distress syndrome in the developing world. A clinical trial of the bubbleCPAP device at the Queen Elizabeth Central Hospital in Blantyre, Malawi showed that the device significantly improved the survival of neonates in respiratory distress. At a significantly lower price point, the Pumani bubbleCPAP has also been proven to deliver therapeutic pressures and flows comparable to bubbleCPAP systems used in the United States.

 

 

Current Status and Next Steps:

 

With support from a Saving Lives at Birth transition grant, Rice360, its partners, and the Malawi Ministry of Health have scaled up implementation of the device to all central and district hospitals in Malawi. Additionally, an award from GSK and Save the Children is funding the roll out of this life-saving technology in Zambia, Tanzania, and South Africa. Plans are also underway to further expand to Christian Health Association of Malawi (CHAM) facilities, which provide approximately 40% of the country’s primary health care services.

 

The rollout of Rice360’s bubbleCPAP device includes rigorous training and continuous mentorship of health workers to ensure competency. In an effort to normalize use of bubbleCPAP technology in Malawi, support is being provided to nursing and clinical officer training schools to integrate it into their curricula, and bubbleCPAP is being included in standard of care protocols.

 

A commercial version of the Pumani bubbleCPAP device can now be purchased from 3rd Stone Design and comes with a teaching module, user manual, repair manual and a spare parts kit. Interested organizations/individuals can contact info@3rdstonedesign.com.